Celsius Therapeutics

About:

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

Website: http://www.celsiustx.com

Twitter/X: celsiustx

Top Investors: Google Ventures, Catalio Capital Management, Alexandria Venture Investments, Amplitude Venture Capital, Section 32

Description:

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients. The company is a group of scientists, technologists, computational biologists, clinicians, and drug hunters who use single-cell genomics and machine learning analysis to find new drugs. Celsius Therapeutics was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Total Funding Amount:

$148M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)celsiustx.com

Founders:

Aviv Regev, Christoph Lengauer, Jeffrey Bluestone, Ramnik Xavier, Vijay Kuchroo

Number of Employees:

11-50

Last Funding Date:

2022-03-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai